Sana Biotechnology, INC Form 4 insider transactions
NASDAQ
Christian Hordo, EVP and Chief Business Officer of Sana Biotechnology, reports the acquisition of stock options and restricted stock units.
NASDAQ
Nathan Hardy, EVP and CFO of Sana Biotechnology, reports acquisition of stock options and restricted stock units.
NASDAQ
Bernard J. Cassidy, EVP & General Counsel of Sana Biotechnology, reports the acquisition of stock options and restricted stock units.